Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.
- Chamber
- Senate
- Introduced
- Mar 21, 2025
- Last action
- Jun 4, 2026 — REFERRED TO HEALTH
- Session
- 2025-2026
- Momentum
- 58 · Moderate